One final stock that's trending very close to triggering a near-term breakout trade is Ventrus Biosciences (VTUS). This is a specialty pharmaceutical company focused on the development and commercialization of late-stage prescription drugs for gastrointestinal disorders, specifically hemorrhoids, anal fissures and fecal incontinence. This stock is off to a solid start in 2012 with shares up over 30%.
If you look at the chart for Ventrus Biosciences, you'll see that this stock has been downtrending for the last month, with shares dropping from a high of $13.53 to a recent low of $9.54 a share. During that sharp move lower, shares of Ventrus have been making lower highs and lower lows, which is bearish technical price action. That said, the stock has held above its 200-day moving average of $9.21 a share, and its bouncing strong today right off its 50-day moving average of $10.07 a share with decent volume. The bounce today is quickly pushing VTUS within range of triggering a near-term breakout trade.Traders should now look for long-biased trades in VTUS if it can manage to trigger a near-term break out above $11.03 to $11.10 a share with high-volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 177,975 shares. If we get that breakout soon, then look for VTUS to re-test its May high of $13.53 and possibly take that level out to the upside. You can buy VTUS off of weakness as long as it does not violate its recent low of $9.54 a share. I would simply use a stop just below $9.54. It's probably a better idea to buy off strength once it takes out $11.03 to $11.10 with high volume, and simply use a stop a few percentage points below those levels. To see more breakout candidates, check out the Breakout Stocks of the Week portfolio on Stockpickr. -- Written by Roberto Pedone in Winderemere, Fla.
Twitter and become a fan on Facebook. This article is commentary by an independent contributor, separate from TheStreet's regular news coverage.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV